Comment on "Evaluation of anticancer therapy-related dermatologic adverse events: Insights from Food and Drug Administration's adverse event reporting system dataset"
J Am Acad Dermatol. 2024 Dec 9:S0190-9622(24)03331-0.
doi: 10.1016/j.jaad.2024.10.117.
Online ahead of print.
1 Department of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna, Bologna, Italy.
2 Department of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna, Bologna, Italy; Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
3 Department of Medical and Surgical Sciences, Alma Mater Studiorum - University of Bologna, Bologna, Italy; Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy. Electronic address: [email protected].